Language selection

Government of Canada / Gouvernement du Canada

Search

Drug shortages in Canada and their impact on public drug plans, 2017/18 to 2019/20.: H82-54/2022E-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.913490&sl=0

Publication information
Department/Agency
  • Canada. Patented Medicine Prices Review Board, issuing body.
TitleDrug shortages in Canada and their impact on public drug plans, 2017/18 to 2019/20.
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Les pénuries de médicaments au Canada et leurs répercussions sur les régimes publics d'assurance-médicaments de 2017-2018 à 2019-2020.
  • Issued also in HTML format.
  • Incorrect catalogue number (H28-54/2022E-PDF) printed in this publication.
  • Includes bibliographical references.
Publishing information
  • Ottawa, ON : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, 2022.
  • ©2022
Description1 online resource (45 pages)
ISBN9780660446226
Catalogue number
  • H82-54/2022E-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: